Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Dreyling

Showing results (171-180 of 336) with videos related to

Pageof 34
Sort By:
British Journal of Haematology|March 29, 2014
Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphomaLee Schwartzberg, Robert Hermann, Ian Flinn, et al.
Haematologica|September 2, 2016
Complementarity determining region-independent recognition of a superantigen by B-cell antigen receptors of mantle cell lymphomaMichael Fichtner, Elmar Spies, Henning Seismann, et al.
Oncology Research and Treatment|September 21, 2021
Rituximab Treatment of Hairy Cell Leukemia in a Patient with Mycobacterium kansasii Infection: A Case ReportCarlo Mümmler, Danmei Zhang, Andreas Zimmermann, et al.
Transplantation and Cellular Therapy|October 1, 2022
Assessment of Healthcare Resource Utilization and Hospitalization Costs in Patients With Relapsed or Refractory Follicular Lymphoma Undergoing CAR-T Cell Therapy With Tisagenlecleucel: Results From the ELARA StudyNathan Hale Fowler, Michael Dickinson, Monalisa Ghosh, et al.
Annals of Hematology|December 17, 2013
Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantationBernd Metzner, Thomas H Müller, Wolfgang Gebauer, et al.
European Journal of Haematology|April 24, 2023
Long-term outcome in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantationBernd Metzner, Thomas H Müller, Jochen Casper, et al.
Hemasphere|May 9, 2025
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-upFrancesco d'Amore, Massimo Federico, Laurence de Leval, et al.
Leukemia & Lymphoma|November 28, 2017
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendationsMartin Dreyling, Igor Aurer, Sergio Cortelazzo, et al.
European Journal of Haematology|March 11, 2022
Primary radiation therapy in stage I/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysisChukwuka Eze, Isabelle Friedrich, Indrawati Hadi, et al.
International Journal of Hematology|November 20, 2022
Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trialNoriko Fukuhara, Koji Kato, Hideki Goto, et al.
Pageof 34

Showing results (171-180 of 336) with videos related to

Sort By:
Pageof 34
British Journal of Haematology|March 29, 2014
Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphomaLee Schwartzberg, Robert Hermann, Ian Flinn, et al.
Haematologica|September 2, 2016
Complementarity determining region-independent recognition of a superantigen by B-cell antigen receptors of mantle cell lymphomaMichael Fichtner, Elmar Spies, Henning Seismann, et al.
Oncology Research and Treatment|September 21, 2021
Rituximab Treatment of Hairy Cell Leukemia in a Patient with Mycobacterium kansasii Infection: A Case ReportCarlo Mümmler, Danmei Zhang, Andreas Zimmermann, et al.
Transplantation and Cellular Therapy|October 1, 2022
Assessment of Healthcare Resource Utilization and Hospitalization Costs in Patients With Relapsed or Refractory Follicular Lymphoma Undergoing CAR-T Cell Therapy With Tisagenlecleucel: Results From the ELARA StudyNathan Hale Fowler, Michael Dickinson, Monalisa Ghosh, et al.
Annals of Hematology|December 17, 2013
Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantationBernd Metzner, Thomas H Müller, Wolfgang Gebauer, et al.
European Journal of Haematology|April 24, 2023
Long-term outcome in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantationBernd Metzner, Thomas H Müller, Jochen Casper, et al.
Hemasphere|May 9, 2025
Peripheral T- and natural killer-cell lymphomas: ESMO-EHA Clinical Practice Guideline for diagnosis, treatment, and follow-upFrancesco d'Amore, Massimo Federico, Laurence de Leval, et al.
Leukemia & Lymphoma|November 28, 2017
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendationsMartin Dreyling, Igor Aurer, Sergio Cortelazzo, et al.
European Journal of Haematology|March 11, 2022
Primary radiation therapy in stage I/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysisChukwuka Eze, Isabelle Friedrich, Indrawati Hadi, et al.
International Journal of Hematology|November 20, 2022
Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trialNoriko Fukuhara, Koji Kato, Hideki Goto, et al.
Pageof 34